Sanofi, a French pharmaceutical business, said on June 2 that it has agreed to purchase Blueprint Medicines Corporation, a biopharmaceutical company based in the United States that specialises in systemic mastocytosis, a rare immunological condition. Sanofi would pay $129.00 per share in cash under the terms of the transaction,
đź“„Company Profiles
Company Profile is an initiative by StartupTalky to publish verified information on different startups and organizations. The content in this post has been approved by Alzheon. Neurodegenerative diseases are disorders that result in the progressive loss of structure or function of neurons, negatively impacting cognitive and physical abilities. As per
đź“„Company Profiles
Company Profile is an initiative by StartupTalky to publish verified information on different startups and organizations. The content in this post has been approved by Biocon Limited. The healthcare marketplace is drastically evolving with many therapeutic solutions. Biopharmaceutical is one such discovery in the healthcare sector that is treated as
đź“„Company Profiles
Company Profile is an initiative by StartupTalky to publish verified information on different startups and organizations. The content in this post has been approved by Cipla Limited. Pharma industries are one of the most crucial industries as they are considered the largest contributors to a country's economy. We
đź“„Company Profiles
Company Profile is an initiative by StartupTalky to publish verified information on different startups and organizations. The content in this post has been approved by Pfizer. Health and Human Services Secretary Alex Azar said that the US was currently manufacturing doses for all six potential vaccines backed by President Donald